
|Articles|June 22, 2011
- Psychiatric Times Vol 28 No 6
- Volume 28
- Issue 6
Einstein’s Happiest Moment -for Susanne
Author(s)Richard M. Berlin, MD
"Einstein’s happiest moment...occurred when he realized...a falling man falling...beside a falling apple..."
Advertisement
POETRY OF THE TIMES
Einstein’s happiest moment
occurred when he realized
a falling man falling
beside a falling apple
could also be described
as an apple and a man at rest
while the world rises around them.
And my happiest moment
occurred when I realized
you were falling for me,
right down to the core, and the rest,
relatively speaking, has flown past
faster than the speed of light.
Articles in this issue
over 15 years ago
Feeling Socially Safeover 15 years ago
Avoiding SRI Discontinuation Syndromeover 15 years ago
Drs McGlashan and Woods Respond to Dr Feinbergover 15 years ago
Obama Drug Misuse Strategy Targets Physician Educationover 15 years ago
Alfred M. Freedman, MD, 1917-2011over 15 years ago
Is It Treatment-Refractory Schizophrenia . . . And if It Is?over 15 years ago
Are We Training Psychiatrists to Provide Only Medication Management?over 15 years ago
Effects of Early Parental DepressionAdvertisement
Related to this article

How to interpret antipsychotic drug levels in schizophrenia: when labs mislead, when levels help adherence and toxicity checks, and why serial monitoring matters.

Male athletes with anorexia often go unnoticed as “discipline”; learn red flags, sport-specific risks, health consequences, and treatment steps for earlier diagnosis.

Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.

Therapeutic drug monitoring takes guesswork out of antipsychotic care—spotting nonadherence, guiding dose targets, and defining response thresholds and the “point of futility” in schizophrenia.

A psychiatric NP shares mentorship lessons, training fixes, and her Psych NP Boot Camp—plus practical tips to close prescriber gaps and improve team-based care.

TRD often mislabels depression; learn why MDD heterogeneity demands tailored treatments and when “difficult-to-treat” fits better.

First US TRD Awareness Day spotlights treatment-resistant depression, urging earlier recognition, stigma-breaking support, and renewed hope for patients and caregivers.
Advertisement
Advertisement
Trending on Psychiatric Times
1
What Makes Us Human? The Role of Psychiatry and the Future DSM
2
The First Ever Treatment-Resistant Depression Awareness Day
3
Relief Is Not Free: A Case Study of Athlete Cannabis Use
4
How Best to Manage Treatment-Resistant Depression
5

